BioWorld-International-2004-01-07
Celltech Details Phase III Trial Plans For CDP870 In Crohn's
Celltech Details Phase III Trial Plans For CDP870 In Crohn's
A Phase III program in Crohn's disease is under way to evaluate a compound being developed by Celltech Group plc. (BioWorld International)

